Physician

Adam Mor, M.D.

According to 2025 Medicare claims, Adam Mor, M.D. (NPI: 1013144120) practices rheumatology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (NPI: 1861907321; TIN: 135598093) and primary practice location at 10032-3729. Mor is affiliated with the NewYork Quality Care (ACO ID: A2571), participating under the MSSP model.

Mor's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 28 traditional Medicare patients, billed 96 HCPCS/CPT codes, and received $10,606 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 112 prescription claims across 26 beneficiaries totaling $209,962 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 1 records totaling $17. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $4,004 and ending at $10,606. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $33,539 to $209,962. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$5.3K$11K2019 Medicare payment: $4,004 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,875 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $10,642 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $7,647 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $9,417 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $10,606 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20193040$4,004
20203465$5,875
20213491$10,642
20222667$7,647
20233285$9,417
20242896$10,606

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$105K$210K2015 Drug cost: $33,539 (USD; Tot_Drug_Cst)2016 Drug cost: $113,180 (USD; Tot_Drug_Cst)2017 Drug cost: $130,241 (USD; Tot_Drug_Cst)2018 Drug cost: $174,319 (USD; Tot_Drug_Cst)2020 Drug cost: $14,328 (USD; Tot_Drug_Cst)2021 Drug cost: $28,785 (USD; Tot_Drug_Cst)2022 Drug cost: $31,100 (USD; Tot_Drug_Cst)2023 Drug cost: $195,032 (USD; Tot_Drug_Cst)2024 Drug cost: $209,962 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201514181$33,539
201615197$113,180
201715234$130,241
2018N/R84$174,319
2019N/RN/RN/R
2020N/R12$14,328
2021N/R40$28,785
20221235$31,100
202328131$195,032
202426112$209,962

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more1745$117

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab21588$197,224
PrednisonePrednisone431,268$322

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$17GlaxoSmithKline, LLC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam Mor, M.D.?

Tedicare shows public-source Medicare data for Adam Mor, M.D. (NPI 1013144120), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam Mor, M.D. have ACO affiliation data?

Adam Mor, M.D. is shown with ACO affiliation data for NewYork Quality Care (MSSP, ACO ID A2571).

What billing organization is linked to Adam Mor, M.D.?

Adam Mor, M.D. is linked to TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (billing NPI 1861907321) in the available physician profile data.

Does Adam Mor, M.D. have Open Payments data?

Adam Mor, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.